Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
520316
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/16/1725
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
||
|
FDA ORPHAN DRUG |
533916
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
||
|
FDA ORPHAN DRUG |
669018
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
||
|
FDA ORPHAN DRUG |
698219
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
875125-19-2
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
PRIMARY | |||
|
EF-15
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
PRIMARY | |||
|
79V7Q9VIWQ
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
PRIMARY | |||
|
100000179837
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
PRIMARY | |||
|
C167012
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
PRIMARY | |||
|
10799
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
PRIMARY | |||
|
DB14991
Created by
admin on Mon Mar 31 21:22:59 GMT 2025 , Edited by admin on Mon Mar 31 21:22:59 GMT 2025
|
PRIMARY |
ACTIVE MOIETY